{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:32:20Z","timestamp":1778171540411,"version":"3.51.4"},"reference-count":27,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T00:00:00Z","timestamp":1681171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Primary sclerosing cholangitis (PSC) is the leading indication of liver transplantation (LT) among autoimmune liver disease patients. There is a scarcity of studies comparing survival outcomes between living-donor liver transplants (LDLT)s and deceased-donor liver transplants (DDLTs) in this population. Using the United Network for Organ Sharing database, we compared 4679 DDLTs and 805 LDLTs. Our outcome of interest was post-LT patient survival and post-LT graft survival. A stepwise multivariate analysis was performed, adjusting for recipient age, gender, diabetes mellitus, ascites, hepatic encephalopathy, cholangiocarcinoma, hepatocellular carcinoma, race, and the model for end-stage liver disease (MELD) score; donor\u2019 age and sex were also included to the analysis. According to univariate and multivariate analysis, LDLT had a patient and graft survival benefit compared to DDLT (HR, 0.77, 95% CI 0.65\u20130.92; p &lt; 0.002). LDLT patient survival (95.2%, 92.6%, 90.1%, and 81.9%) and graft survival (94.1%, 91.1%, 88.5%, and 80.5%) at 1, 3, 5, and 10 years were significantly better than DDLT patient survival (93.2%, 87.6%, 83.3%, and 72.7%) and graft survival (92.1%, 86.5%, 82.1%, and 70.9%) (p &lt; 0.001) in the same interval. Variables including donor and recipient age, male recipient gender, MELD score, diabetes mellitus, hepatocellular carcinoma, and cholangiocarcinoma were associated with mortality and graft failure in PSC patients. Interestingly, Asians were more protected than Whites (HR, 0.61; 95% CI, 0.35\u20130.99; p &lt; 0.047), and cholangiocarcinoma was associated with the highest hazard of mortality (HR, 2.07; 95% CI, 1.71\u20132.50; p &lt; 0.001) in multivariate analysis. LDLT in PSC patients were associated with greater post-transplant patient and graft survival compared to DDLT patients.<\/jats:p>","DOI":"10.3390\/jcm12082807","type":"journal-article","created":{"date-parts":[[2023,4,11]],"date-time":"2023-04-11T03:11:23Z","timestamp":1681182683000},"page":"2807","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Living-Donor Liver Transplant and Improved Post-Transplant Survival in Patients with Primary Sclerosing Cholangitis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7148-5450","authenticated-orcid":false,"given":"Leandro","family":"Sierra","sequence":"first","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4158-9264","authenticated-orcid":false,"given":"Romelia","family":"Barba","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3319-9664","authenticated-orcid":false,"given":"Bryan","family":"Ferrigno","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Goyes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Loyola Medicine\u2014MacNeal Hospital, Berwyn, IL 60402, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfor","family":"Diaz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vilas R.","family":"Patwardhan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behnam","family":"Saberi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6821-0416","authenticated-orcid":false,"given":"Alan","family":"Bonder","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,4,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","article-title":"An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort","volume":"55","author":"Bakhshi","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet Lond. Engl."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"American College of Gastroenterology ACG Clinical Guideline: Primary Sclerosing Cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00535-020-01681-z","article-title":"Emerging therapies in primary sclerosing cholangitis: Pathophysiological basis and clinical opportunities","volume":"55","author":"Vesterhus","year":"2020","journal-title":"J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2147\/CEG.S105872","article-title":"Primary sclerosing cholangitis: Diagnostic and management challenges","volume":"10","author":"Sirpal","year":"2017","journal-title":"Clin. Exp. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/MCG.0000000000001271","article-title":"Increased Posttransplant Mortality for Autoimmune Hepatitis Compared With Other Autoimmune Liver Diseases","volume":"54","author":"Lee","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/hep.27307","article-title":"Superior survival using living donors and donor-recipient matching using a novel living donor risk index","volume":"60","author":"Goldberg","year":"2014","journal-title":"Hepatol. Baltim. Md."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1097\/TP.0b013e31821694b3","article-title":"Current trends in living donor liver transplantation for primary sclerosing cholangitis","volume":"91","author":"Goldberg","year":"2011","journal-title":"Transplantation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e14031","DOI":"10.1111\/ctr.14031","article-title":"Living vs deceased donor liver transplantation in cholestatic liver disease: An analysis of the OPTN database","volume":"34","author":"Ziogas","year":"2020","journal-title":"Clin. Transplant."},{"key":"ref_10","first-page":"1214","article-title":"Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients","volume":"22","author":"Gordon","year":"2016","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jceh.2020.02.002","article-title":"Good Long-Term Outcomes in Patients With Primary Sclerosing Cholangitis Undergoing Living Donor Liver Transplantation","volume":"10","author":"Choudhary","year":"2020","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1001\/jamasurg.2022.3327","article-title":"Survival Benefit of Living-Donor Liver Transplant","volume":"157","author":"Jackson","year":"2022","journal-title":"JAMA Surg."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajt.16494","article-title":"OPTN\/SRTR 2019 Annual Data Report: Liver","volume":"21","author":"Kwong","year":"2021","journal-title":"Am. J. Transplant. Off. J. Am. Soc. Transplant. Am. Soc. Transpl. Surg."},{"key":"ref_14","unstructured":"(2023, February 11). Clinical Outcomes of Living versus Deceased Donor Liver Transplantation for Primary Sclerosing Cholangitis: A Multicenter 15 Year Experience. Available online: https:\/\/atcmeetingabstracts.com\/abstract\/clinical-outcomes-of-living-versus-deceased-donor-liver-transplantation-for-primary-sclerosing-cholangitis-a-multicenter-15-year-experience\/."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s11605-009-0898-3","article-title":"Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis","volume":"13","author":"Kashyap","year":"2009","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1007\/s11605-010-1256-1","article-title":"Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database","volume":"14","author":"Kashyap","year":"2010","journal-title":"J. Gastrointest. Surg. Off. J. Soc. Surg. Aliment. Tract"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/ajt.16864","article-title":"Long-term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry","volume":"22","author":"Heinemann","year":"2022","journal-title":"Am. J. Transplant."},{"key":"ref_18","first-page":"302","article-title":"Ethnic Disparities in Liver Transplantation","volume":"7","author":"Kemmer","year":"2011","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Thuluvath, P.J., Amjad, W., and Zhang, T. (2020). Liver transplant waitlist removal, transplantation rates and post-transplant survival in Hispanics. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0244744"},{"key":"ref_20","first-page":"1019","article-title":"Living-Donor Liver Transplantation in the United States: Evolution of Frequency, Outcomes, Center Volumes and Factors Associated with Outcomes","volume":"27","author":"Cotter","year":"2021","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1002\/lt.23956","article-title":"Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012","volume":"20","author":"Hoehn","year":"2014","journal-title":"Liver Transpl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/SLA.0000000000001383","article-title":"Defining Long-term Outcomes with Living Donor Liver Transplantation in North America","volume":"262","author":"Olthoff","year":"2015","journal-title":"Ann. Surg."},{"key":"ref_23","first-page":"1355","article-title":"Waitlist Survival of Patients with Primary Sclerosing Cholangitis in the Post-MELD Era","volume":"17","author":"Goldberg","year":"2011","journal-title":"Liver Transplant. Off. Publ. Am. Assoc. Study Liver Dis. Int. Liver Transplant. Soc."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.3748\/wjg.v22.i21.4966","article-title":"How important is donor age in liver transplantation?","volume":"22","author":"Solanas","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4174\/astr.2014.86.4.184","article-title":"Outcomes of living donor liver transplantation using elderly donors","volume":"86","author":"Han","year":"2014","journal-title":"Ann. Surg. Treat. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.24494","article-title":"Liver transplant recipient survival benefit with living donation in the MELD allocation era","volume":"54","author":"Berg","year":"2011","journal-title":"Hepatol. Baltim. Md"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/bjs.5528","article-title":"Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma","volume":"94","author":"Lo","year":"2007","journal-title":"Br. J. Surg."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2807\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:13:41Z","timestamp":1760123621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/8\/2807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,11]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["jcm12082807"],"URL":"https:\/\/doi.org\/10.3390\/jcm12082807","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,11]]}}}